Abstract P4-15-12: Rebastinib in combination with eribulin ablates TIE2-expressing macrophages, reduces metastasis, and increases survival in the PyMT metastatic breast cancer model
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2011 ◽
2016 ◽
2013 ◽
Vol 28
(11)
◽
pp. 2357-2367
◽
Keyword(s):
Keyword(s):
Keyword(s):
2011 ◽
Vol 27
(6)
◽
pp. 563-572
◽